Investigadores de OHSU identifican un promisorio tratamiento de última generación contra el cáncer
February 10, 2023
El descubrimiento de un químico apunta a la creación de inhibidores de PARP-1 de última generación, un objetivo crítico en cánceres de ovario, mama y próstata.
OHSU researchers identify promising next-generation cancer treatment
February 10, 2023
Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.
Study confirms the unique danger of postpartum breast cancers
October 14, 2022
A postpartum cancer diagnosis can move women who appear to have good prognosis into a high-risk category.
A better roadmap for beating a deadly leukemia
August 09, 2022
Using massive data set, OHSU researchers zero in on potential drug target to stop acute myeloid leukemia.
New treatment strategy aims to stop rare liver cancer
June 15, 2022
OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.
Taking a systems approach to beating cancer
May 04, 2022
Laura Heiser uses systems biology in her effort to reveal, counter tumor drug resistance.
Blood test could reveal transition to cancer in people at risk
April 25, 2022
Test developed by OHSU researchers could enable treatment early, when cancer is more likely to be curable.
Innovation massively expands view into workings of single cells
July 06, 2021
New method yields 10 times more data, reduces gene sequencing costs by one third.
Targeted ‘radioligand’ improves survival in advanced prostate cancer
June 03, 2021
Injected agent targets radiation to prostate cancer cells, sparing most normal tissues.
Understanding the aggressive breast cancers missed by mammogram screening
June 30, 2020
Research by OHSU, Oregon State University points to an aggressive form of breast cancer not detected readily by screening.
Cancer genome study reveals big window for early detection
February 05, 2020
New findings suggest that it will be possible to find and treat many cancers early.
Study overturns basic tenet in leukemia biology
November 18, 2019
Findings could lead to better therapies for acute myeloid leukemia, among most difficult cancers to treat.
A new prescription for cancer: Exercise
October 16, 2019
Updated guidance concludes activity tailored to the individual can reduce side effects, improve quality of life.
Care for lung cancer pain, suffering linked to improved survival
September 19, 2019
OHSU study of 23,000 VA patients finds timing of palliative care is pivotal.
Targeted therapy stops a rare, joint-destroying tumor
August 20, 2019
OHSU cancer researcher helped lead study finding first effective drug therapy for tenosynovial giant cell tumor, or TGCT.
‘Bone in a dish’ opens new window on cancer initiation, metastasis, bone healing
August 06, 2019
Like real bone, the material developed at OHSU has a 3D mineral structure populated with living cells, providing a unique model to study bone function, diseases, regeneration.
New questions about the tradeoffs in ‘accelerated’ cancer drug studies
April 01, 2019
Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds.
Making cancer clinical trials SMMART
November 16, 2018
OHSU is giving cancer researchers new ability to test drug combinations aimed at overwhelming a tumors’ ability to adapt.
Tumor cells fuse with immune cells and become more aggressive
September 12, 2018
The hybrid cells, readily detected in cancer patients’ blood, gain new powers to mobilize and form new tumors.
